Document is current
Any future updates will be listed below
-
Authors
Hayashino, Kenta
Seike, Keisuke https://orcid.org/0000-0002-3484-0265
Masunari, Taro
Hashida, Risa
Oka, Satoshi
Fujiwara, Yuki
Terao, Toshiki
Kitamura, Wataru
Kobayashi, Hiroki
Kamoi, Chihiro
Kondo, Takumi
Fujiwara, Hideaki
Asada, Noboru
Ennishi, Daisuke
Fujii, Keiko
Fujii, Nobuharu
Maeda, Yoshinobu
-
Funding
Funding for this research was provided by:
Okayama University
- License Information
-
More Information
Article History
Received: 19 February 2025
Revised: 28 May 2025
Accepted: 28 May 2025
First Online: 17 June 2025
Declarations
:
: T.M. has received honoraria from Bristol Myers Squibb. D.E., N.F., and Y.M. have received honoraria from Novartis, Bristol Myers Squibb, Gilead Sciences, and Janssen Pharmaceutical. K.F. has received honoraria from Bristol Myers Squibb and Gilead Sciences. The others have no conflict of interest for this study.
: All procedures performed in the study were in accordance with the ethical standards of the institutional and/or national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the institutional review board (#2405-051).
: This is a retrospective observational study and obtaining written consent was not mandatory. All participants did not provide any denial to this study documents that were made available to them on an opt-out manner on the Web. The opt-out method was approved by the institutional review board.
